This company listing is no longer active
Probi (0GZB) Stock Overview
Researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
0GZB Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Probi AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 203.00 |
| 52 Week High | SEK 209.00 |
| 52 Week Low | SEK 203.00 |
| Beta | 0.56 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 36.42% |
| 5 Year Change | -53.60% |
| Change since IPO | 301.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GZB | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | 2.0% | 1.0% |
| 1Y | n/a | 4.8% | 16.8% |
Return vs Industry: Insufficient data to determine how 0GZB performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how 0GZB performed against the UK Market.
Price Volatility
| 0GZB volatility | |
|---|---|
| 0GZB Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 7.5% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0GZB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0GZB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 154 | Anita Johansen | www.probi.com |
Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children’s, women’s, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks.
Probi AB (publ) Fundamentals Summary
| 0GZB fundamental statistics | |
|---|---|
| Market cap | SEK 2.07b |
| Earnings (TTM) | SEK 40.62m |
| Revenue (TTM) | SEK 618.29m |
Is 0GZB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GZB income statement (TTM) | |
|---|---|
| Revenue | SEK 618.29m |
| Cost of Revenue | SEK 362.84m |
| Gross Profit | SEK 255.45m |
| Other Expenses | SEK 214.82m |
| Earnings | SEK 40.62m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Apr 04, 2023
| Earnings per share (EPS) | 3.57 |
| Gross Margin | 41.32% |
| Net Profit Margin | 6.57% |
| Debt/Equity Ratio | 0% |
How did 0GZB perform over the long term?
See historical performance and comparisonDividends
Does 0GZB pay a reliable dividends?
See 0GZB dividend history and benchmarks| Probi dividend dates | |
|---|---|
| Ex Dividend Date | May 05 2023 |
| Dividend Pay Date | May 11 2023 |
| Days until Ex dividend | 1173 days |
| Days until Dividend pay date | 1167 days |
Does 0GZB pay a reliable dividends?
See 0GZB dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/03/27 20:59 |
| End of Day Share Price | 2022/12/28 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Probi AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jakob Lembke | ABG Sundal Collier Sponsored |
| null null | ABG Sundal Collier Sponsored |